Weight Loss Information logo

Axokine Diet Drug for Obesity Treatment
Form of Ciliary Neurotrophic Factor in Weight Loss Program
Weight Loss Information

Questions About Obesity Medications
Appetite Suppressants - Anti-Obesity Drugs - Prescription Obesity Drugs
Development of Diet Pills - Meridia Short-Term Obesity Drug - Xenical Lipase Inhibitors - Xenical Study
Orlistat & Obesity Management - Orlistat Weight Loss Study - Sibutramine FDA Approved Obesity Drug
Sibutramine Study - Obesity Drugs & Diabetes - Risks of Weight Loss Pills - Adipex Obesity Drug
Side Effects of Adipex - Phentermine to Reduce Appetite - Side Effects of Phentermine


Axokine Diet Drug for the Treatment of Obesity

Regeneron Pharmaceuticals (Nasdaq:REGN) announced today that it will move forward with the Phase III development program of Axokine for the treatment of obesity. This decision was made following a meeting with the U.S. Food and Drug Administration (FDA) to review results from the initial pivotal diet drug trial completed earlier this year and the Company's plans for future development of Axokine as an aid to weight loss.

More Diet Drug Trials
The remaining Phase III program is expected to consist of a one-year confirmatory pivotal trial similar to the initial trial, a separate one-year study in obese type 2 diabetic patients, and several smaller and shorter studies. The trials will continue to enroll a broad range of overweight and obese individuals. In total, approximately 2,300 additional people are expected to be enrolled in future trials.

Axokine Weight Loss Drug Trial
Axokine has the potential to be a new weapon in the battle against obesity. Though it causes moderate weight loss in most patients, a significant proportion of patients exhibit substantial weight loss with Axokine treatment. In the completed pivotal trial, almost three times as many patients treated with Axokine plus a weight control program lost over 10 percent of their body weight over twelve months of treatment compared to those on a weight control program alone (11.3 percent versus 4.2 percent), and these patients averaged more than 30 pounds of weight loss."

About Axokine Diet & Weight Loss Drug
Axokine is a modified form of ciliary neurotrophic factor (CNTF), which is in Phase III clinical development by Regeneron Pharmaceuticals for the treatment of obesity. This investigational compound has a novel mechanism of action - the inhibition of hunger signals that stimulate appetite. Ongoing Phase III trials are studying the safety and efficacy of Axokine.

Source: Press Release, Sept. 9, 2003

Weight Loss Drugs

ACC2 Weight Loss Enzyme - Appetite Suppressant Drugs - Health Risks Appetite Suppressant - Appetite Suppressants Weight Loss - Axokine Diet Drug - C75 Weight Loss Compound - Cholecystokinin Weight Loss - Dexfenfluramine Weight Loss - Didrex Diet Drugs - Depression Diet Drugs - Diet Drugs Usage - Diet Drugs - Diet Pills Eating Exercise - Diet Pills Weight Regain - Weight Loss Drugs Diet Program - Fen Phen - Fenfluramine Weight Loss Drugs - Fluoxetine Weight Loss - GIP Hormone Weight Loss Drug - Ionamin Diet Drugs - KB-141 Weight Loss Compound - Meridia Diet Drugs - Meridia Weight Loss Drug Ban - New Weight Loss Drugsl - Obesity Drugs Guidelines - Obesity Prescription Drug Markets - Obesity Weight Loss Drugs Treatment - Orlistat Lipase Inhibitor - Orlistat Drug Treatment Obesity - Anti-Obesity Drugs Trial Orlistat & Sibutramine - Orlistat Glucose Study - Orlistat Weight Management Advice - Orlistat Unsatisfactory Weight Reduction - Orlistat / Xenical Pills Weight Reduction - Phentermine Appetite Lowering Diet Drugs - Phentermine Weight Loss Drugs - Phenylpropanolamine (PPA) Weight Loss Drug - Prescription Drugs Treatment of Obesity - Sibutramine Binge Eating - Comparison Sibutramine Dexfenfluramine - Sibutramine Health Safety - Sibutramine Energy Weight Management - Sibutramine Abuse - Sibutramine Weight Loss Trial - Sibutramine Weight Loss Drugs - Tenuate Diet Drugs - Topiramate Anti-Obesity Drug - Weight Loss Drug Therapy - Weight Loss Drugs Review - Weight Loss Medication Candidate Evaluation - Weight Loss Medications Guidelines - Weight Loss Anti-Obesity Drugs - Weight Loss Study Orlistat - Weight Loss Pills Overdose - Minimize Health Risks Weight Loss Pills - Weight Loss Pills Do They Work? - Weight Management Drugs Advice - Zenical Weight Loss Drug

 

Weight Loss Information - Rapid Weight Loss - Diet Program - How to Lose Weight - Best Weight Loss Goals
Weight Loss Advice - Healthy Balanced Diet - Body Fat Percentage - Diets & Weight Loss Programs
Information on Weight Loss Diets - How to Reduce Weight - Weight Management - Weight Loss Surgery Information
Weight Loss Surgery Benefits/Risks - Weight Loss Drugs Advice - Weight Loss Pills / Weight Loss Pills Information
Xenical Weight Loss Drugs - Meridia/Sibutramine Pills - Guide to Diet Pills - Calorie Needs - Weight Loss Supplements
How to Control Weight - Body Mass Index Calculator - Exercise & Fitness to Lose Weight - Weight Health Issues - Obesity
Treatment of Obesity - Advice About Weight Loss - Questions on Weight Loss & Diet - Weight Loss Advice for Women
Weight Loss Advice for Diabetics - Weight Loss Advice for Teenagers - Weight Loss Advice for Adolescents
Diet & Weight Information - Weight Loss Support - Obesity Drug Treatment - Obesity & Gallstones - How to Lower Cholesterol
Dietary Guidelines - Protein, Carbs & Diet - Carbohydrates & Weight Loss - Weight Gain at College
Weight Gain After Quit Smoking - Weight Control in Menopause - Weight Gain in Pregnancy - Weight Control in Pregnancy
Weight Loss Breast-Feeding - Healthy Weight Range - Healthy Weight Loss Diet - Waist Circumference - Weight Cycling
Weight Health Risks - Weight Risks Assessment - Weight Reduction Tips - Weight Loss Guidelines - Weight Loss Products
Weight Loss Tools - Weight Maintenance

Enquiries: Contact Us. See also Terms of Use
© 2003-2017 Weight Loss Information. All Rights Reserved.